What Imodium does

Imodium is an over-the-counter consumer health brand that manufactures and markets anti-diarrheal medications containing Loperamide HCl as the active ingredient. The product line spans five formats: IMODIUM A-D Caplets and Softgels (2mg Loperamide HCl per unit) for adults and children 6+, IMODIUM A-D Oral Solution (liquid Loperamide HCl), a pediatric oral solution FDA-approved for ages 6 through 11, and IMODIUM Multi-Symptom Relief Caplets, which combine Loperamide with Simethicone to additionally address gas, bloating, cramps, and pressure. The active ingredient works by slowing gut motility, allowing greater absorption of fluids and salts to restore the digestive system's natural rhythm. The brand holds the #1 doctor recommended OTC anti-diarrheal positioning in the US market, with over 35 years of continuous market presence.

The brand operates under Kenvue Brands LLC, a subsidiary of Kenvue Inc. (NYSE: KVUE), which was spun off from Johnson & Johnson's consumer health division in November 2023. Imodium does not sell direct; revenue is generated through one-time OTC retail purchases via drug stores, supermarkets, and grocery chains, supported by a "Where to Buy" locator and bilingual (English/Spanish) consumer education content. Target customer segments include general adult consumers experiencing acute or chronic diarrhea, parents and caregivers of children ages 6+, travelers managing travelers' diarrhea, and IBS patients seeking symptom management. Pricing is set at retail and is not publicly disclosed on the brand's website.

Operationally, Imodium functions as a brand within Kenvue's Self Care portfolio alongside Tylenol, Motrin, Zyrtec, and Nicorette, sharing Kenvue's enterprise distribution, manufacturing, and regulatory infrastructure. The brand's competitive position is anchored on doctor recommendation equity, format variety, and a distinctive pediatric FDA approval, rather than on novel technology or proprietary data assets.

Name

Imodium

Legal name

Kenvue Brands LLC

Website

https://imodium.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Imodium is an over-the-counter anti-diarrheal medication brand under Kenvue Inc., selling Loperamide-based products (caplets, softgels, liquid, children's, and multi-symptom formulas) to US consumers via drug stores and supermarkets for acute, chronic, and travel-related diarrhea relief.

Ownership category

akta.pro rank

Product category

OTC Gastrointestinal Pharmaceuticals

akta.pro primary industry

Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC) (CRADAMAE)

akta.pro secondary industry

Pediatric OTC Medicines (HLAIADAL)

Keywords

• OTC anti-diarrheal medication
• Gastrointestinal relief
• Consumer health products
• Loperamide treatments
• Digestive health remedies

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Operations, Personnel, Others

Revenue model

1. OTC Pharmaceutical Retail Sales: Imodium generates revenue through one-time retail purchases of over-the-counter anti-diarrheal medications. Products are sold through drug stores, supermarkets, and retail locations without prescription. Multiple product formats (softgels, caplets, liquid) at various price points target different consumer preferences.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Imodium manufactures and sells over-the-counter anti-diarrheal medications containing Loperamide HCl for adults and children ages 6 and up. The product portfolio spans five formats — caplets, softgels, oral solution, children's oral solution, and a multi-symptom caplet combining loperamide with simethicone — all sold without prescription through drug stores, supermarkets, and grocery retailers in the United States.

Product overview

Imodium is a portfolio of over-the-counter (OTC) anti-diarrheal medications containing the active ingredient Loperamide. The product line includes five distinct formats: IMODIUM Multi-Symptom Relief Caplets (combining Loperamide with Simethicone for gas/bloating relief), IMODIUM A-D Oral Solution (liquid format), Children's A-D Oral Solution (pediatric formulation for ages 6+), A-D Softgels (gelatin capsules), and A-D Caplets (tablet format). All products work by slowing gut motility to restore digestive natural rhythm and are available without prescription.

Differentiator

Problem solved

Functional benefit

Brands

• IMODIUM A-D: Over-the-counter anti-diarrheal medication line including caplets, softgels, and oral solution with loperamide HCl as the active ingredient.
• IMODIUM A-D for Children
• IMODIUM Multi-Symptom Relief

Products and services

• IMODIUM Multi-Symptom Anti-Diarrheal Relief Caplets OTC anti-diarrheal caplets combining Loperamide and Simethicone to relieve diarrhea along with gas, bloating, cramps, and pressure; intended for adult consumers seeking multi-symptom relief.
• IMODIUM A-D Anti-Diarrheal Oral Solution (Liquid) Liquid OTC anti-diarrheal medicine containing Loperamide HCl 1 mg per 7.5 mL for adults seeking fast-acting relief from diarrhea symptoms.
• IMODIUM A-D Anti-Diarrheal Liquid Oral Solution for Children Ages 6 and Up FDA-approved OTC anti-diarrheal liquid oral solution containing Loperamide HCl 1 mg per 7.5 mL, formulated for children ages 6 through 11.
• IMODIUM A-D Anti-Diarrheal Softgels OTC anti-diarrheal softgels containing 2 mg Loperamide HCl per capsule, intended for adults who prefer a smooth-coated, easier-to-swallow format.
• IMODIUM A-D Anti-Diarrheal Caplets OTC anti-diarrheal caplets containing 2 mg Loperamide HCl per caplet for adults and children ages 6 and older.

Quantifiable outcome

• Starts to work within 1 hour to relieve diarrhea symptoms
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Prilosec OTC: Procter & Gamble OTC gastrointestinal brand for frequent heartburn. Sits on the same retailer antacid/digestive sets as Imodium and represents the kind of large-OTC incumbent that competes for planogram space and consumer attention.
• Metamucil: Procter & Gamble fiber supplement brand addressing digestive regularity. Competes with Imodium for the consumer's 'digestive health' mind-share and often occupies adjacent shelf space in the same aisle.
• Align: Procter & Gamble probiotic brand focused on digestive balance. Targets the same 'everyday digestive health' consumer occasions as Imodium and competes for the same category shopper at retail.
• Kenvue Inc. Imodium's publicly traded parent company (NYSE: KVUE), spun off from Johnson & Johnson in 2023. Houses the broader consumer health portfolio (Tylenol, Motrin, Zyrtec, Nicorette) and is the platform through which Imodium is manufactured, distributed, and marketed.
• Tums: Haleon OTC antacid brand. Same OTC digestive-health category and same retail drugstore shelf set as Imodium, though addressing heartburn rather than diarrhea — making it a category-competitor for digestive share of stomach.
• Dulcolax: Sanofi OTC brand for constipation relief. Same OTC gastrointestinal category, same mass retail channels, and same Kenvue-style consumer health brand-building playbook, though serving the opposite end of digestive regularity.

Direct peers

• Gas-X: Haleon (formerly GSK Consumer Healthcare) OTC brand whose active ingredient Simethicone is the exact same one Imodium combined with loperamide in its Multi-Symptom SKU. Strong direct overlap in addressing gas, bloating and pressure symptoms.
• Pepto-Bismol: Procter & Gamble's flagship OTC digestive brand, the closest direct competitor to Imodium in the consumer anti-diarrheal / upset-stomach category. Both are mass-market OTC brands sold through the same drug and grocery channels targeting similar acute symptom use cases.
• Kaopectate: Chattem/Sanofi OTC anti-diarrheal brand competing head-to-head with Imodium on the same drugstore shelves. Operates in the same OTC anti-diarrheal sub-category with overlapping consumer target and channel positioning.

Emerging players

• Culturelle: i-Health / DSM probiotic brand marketed for digestive and gut-health benefits. Competes indirectly with Imodium for consumers seeking non-pharmaceutical digestive wellness solutions, an emerging alternative treatment posture.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Imodium